Fawzy-El-Sayed
K, Mekhemar M, Adam-Klages S, Kabelitz D, Dšrfer C. TLR expression profile of
human gingival margin-derived stem progenitor cells. Med Oral
Patol Oral Cir Bucal. 2016 Jan
1;21 (1):e30-8.
doi:10.4317/medoral.20593
http://dx.doi.org/doi:10.4317/medoral.20593
1.
Larjava H, Wiebe C, Gallant-Behm C, Hart DA, Heino J, HŠkkinen L. Exploring
scarless healing of oral soft tissues. J Can Dent Assoc. 2011;77:b18. |
|
|
|
2.
Pitaru S, McCulloch CA, Narayanan SA. Cellular origins and differentiation
control mechanisms during periodontal development and wound healing. J
Periodontal Res. 1994;29:81-94. |
|
|
|
3.
Sempowski GD, Borrello MA, Blieden TM, Barth RK, Phipps RP. Fibroblast
heterogeneity in the healing wound. Wound Repair Regen. 1995;3:120-31. |
|
|
|
4.
Schor SL, Ellis I, Irwin CR, Banyard J, Seneviratne K, Dolman C, et al.
Subpopulations of fetal-like gingival fibroblasts: characterisation and
potential significance for wound healing and the progression of periodontal
disease. Oral Dis. 1996;2:155-66. |
|
|
|
5.
Phipps RP, Borrello MA, Blieden TM. Fibroblast heterogeneity in the
periodontium and other tissues. J Periodontal Res. 1997;32:159-65. |
|
|
|
6.
HŠkkinen L, Uitto VJ, Larjava H. Cell biology of gingival wound healing.
Periodontol 2000. 2000;24:127-52. |
|
|
|
7.
Widera D, Zander C, Heidbreder M, Kasperek Y, Noll T, Seitz O, et al. Adult
palatum as a novel source of neural crest-related stem cells. Stem Cells.
2009;27:1899-910. |
|
|
|
8.
Marynka-Kalmani K, Treves S, Yafee M, Rachima H, Gafni Y, Cohen MA, et al.
The lamina propria of adult human oral mucosa harbors a novel stem cell
population. Stem Cells. 2010;28:984-95. |
|
|
|
9.
Mitrano TI, Grob MS, Carri—n F, Nova-Lamperti E, Luz PA, Fierro FS, et al.
Culture and characterization of mesenchymal stem cells from human gingival
tissue. J Periodontol. 2010;81:917-25. |
|
|
|
10.
Fournier BP, Ferre FC, Couty L, Lataillade JJ, Gourven M, Naveau A, et al.
Multipotent progenitor cells in gingival connective tissue. Tissue Eng Part
A. 2010;16:2891-9. |
|
|
|
11.
Tomar GB, Srivastava RK, Gupta N, Barhanpurkar AP, Pote ST, Jhaveri HM, et
al. Human gingiva-derived mesenchymal stem cells are superior to bone
marrow-derived mesenchymal stem cells for cell therapy in regenerative
medicine. Biochem Biophys Res Commun. 2010;393:377-83. |
|
|
|
12.
Tang L, Li N, Xie H, Jin Y. Characterization of mesenchymal stem cells from
human normal and hyperplastic gingiva. J Cell Physiol. 2011;226:832-42. |
|
|
|
13.
Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Shi S, et al. Mesenchymal stem cells
derived from human gingiva are capable of immunomodulatory functions and
ameliorate inflammation-related tissue destruction in experimental colitis. J
Immunol. 2009;183:7787-98. |
|
|
|
14.
Moshaverinia A, Chen C, Akiyama K, Ansari S, Xu X, Chee WW, et al. Alginate
hydrogel as a promising scaffold for dental-derived stem cells: an in vitro
study. J Mater Sci Mater Med. 2012;23:3041-51. |
|
|
|
15.
Fawzy El-Sayed KM, Paris S, Becker ST, Neuschl M, De Buhr W, SŠlzer S, et al.
Periodontal regeneration employing gingival margin-derived stem/progenitor
cells: an animal study. J Clin Periodontol. 2012;39:861-70. |
|
|
|
16.
Kawai T, Akira S. The role of pattern-recognition receptors in innate
immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373-84. |
|
|
|
17.
Getts DR, Chastain EM, Terry RL, Miller SD. Virus infection, antiviral
immunity, and autoimmunity. Immunol Rev. 2013;255:197-209. |
|
|
|
18.
Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of
human disease. Nat Immunol. 2004;5:975-9. |
|
|
|
19.
Liotta F, Angeli R, Cosmi L, Fil“ L, Manuelli C, Frosali F, et al. Toll-like
receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem
cells and can inhibit their T-cell modulatory activity by impairing Notch
signaling. Stem Cells. 2008;26:279-89. |
|
|
|
20.
Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune
responses. Nat Immunol. 2004;5:987-95. |
|
|
|
21.
Hwa Cho H, Bae YC, Jung JS. Role of toll-like receptors on human
adipose-derived stromal cells. Stem Cells. 2006;24:2744-52. |
|
|
|
22.
van den Berk LC, Jansen BJ, Siebers-Vermeulen KG, Netea MG, Latuhihin T,
Bergevoet S, et al. Toll-like receptor triggering in cord blood mesenchymal
stem cells. J Cell Mol Med. 2009;13:3415-26. |
|
|
|
23.
Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB.
Toll-like receptors on human mesenchymal stem cells drive their migration and
immunomodulating responses. Stem Cells. 2008;26:99-107. |
|
|
|
24.
Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, et al.
The source of human mesenchymal stromal cells influences their TLR profile as
well as their functional properties. Cell Immunol. 2011;270:207-16. |
|
|
|
25.
Tomic S, Djokic J, Vasilijic S, Vucevic D, Todorovic V, Supic G, et al.
Immunomodulatory properties of mesenchymal stem cells derived from dental
pulp and dental follicle are susceptible to activation by toll-like receptor
agonists. Stem Cells Dev. 2011;20:695-708. |
|
|
|
26.
DelaRosa O, Lombardo E. Modulation of adult mesenchymal stem cells activity
by toll-like receptors: implications on therapeutic potential. Mediators
Inflamm. 2010;2010:865601. |
|
|
|
27.
El-Sayed KM, Paris S, Graetz C, Kassem N, Mekhemar M, Ungefroren H, et al.
Isolation and characterisation of human gingival margin-derived
STRO-1/MACS(+) and MACS(-) cell populations. Int J Oral Sci. 2015;7:80-8. |
|
|
|
28.
Ge S, Mrozik KM, Menicanin D, Gronthos S, Bartold PM. Isolation and
characterization of mesenchymal stem cell-like cells from healthy and
inflamed gingival tissue: potential use for clinical therapy. Regen Med.
2012;7:819-32. |
|
|
|
29.
Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, et
al. Single-colony derived strains of human marrow stromal fibroblasts form
bone after transplantation in vivo. J Bone Miner Res. 1997;12:1335-47. |
|
|
|
30.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D,
et al. Minimal criteria for defining multipotent mesenchymal stromal cells.
The International Society for Cellular Therapy position statement.
Cytotherapy. 2006;8:315-7. |
|
|
|
31.
Liao J, Hu N, Zhou N, Lin L, Zhao C, Yi S, et al. Sox9 potentiates
BMP2-induced chondrogenic differentiation and inhibits BMP2-induced
osteogenic differentiation. PLoS One. 2014;9:e89025. |
|
|
|
32.
Raicevic G, Rouas R, Najar M, Stordeur P, Boufker HI, Bron D, et al.
Inflammation modifies the pattern and the function of Toll-like receptors
expressed by human mesenchymal stromal cells. Hum Immunol. 2010;71:235-44. |
|
|
|
33.
Gronthos S, Akintoye SO, Wang CY, Shi S. Bone marrow stromal stem cells for
tissue engineering. Periodontol 2000. 2006;41:188-95. |
|
|
|
34.
Fawzy El-Sayed KM, Paris S, Becker S, Kassem N, Ungefroren H, FŠndrich F, et
al. Isolation and characterization of multipotent postnatal stem/progenitor
cells from human alveolar bone proper. J Craniomaxillofac Surg.
2012;40:735-42. |
|
|
|
35.
Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luri‡
EA, et al. Precursors for fibroblasts in different populations of
hematopoietic cells as detected by the in vitro colony assay method. Exp
Hematol. 1974;2:83-92. |
|
|
|
36.
Nanci A, Bosshardt DD. Structure of periodontal tissues in health and
disease. Periodontol 2000. 2006;40:11-28. |
|
|
|
37.
Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Pescatori M, Stubbs AP, et al.
Inflammatory conditions affect gene expression and function of human adipose
tissue-derived mesenchymal stem cells. Clin Exp Immunol. 2010;162:474-86. |
|
|
|
38.
Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S. Interferon-gamma
and tumor necrosis factor-alpha differentially affect cytokine expression and
migration properties of mesenchymal stem cells. Stem Cells Dev.
2010;19:693-706. |
|
|
|
39.
van den Berk LC, Jansen BJ, Siebers-Vermeulen KG, Netea MG, Latuhihin T,
Bergevoet S, et al. Toll-like receptor triggering in cord blood mesenchymal
stem cells. J Cell Mol Med. 2009;13:3415-26. |
|
|
|
40.
Kim HS, Shin TH, Yang SR, Seo MS, Kim DJ, Kang SK, et al. Implication of NOD1
and NOD2 for the differentiation of multipotent mesenchymal stem cells
derived from human umbilical cord blood. PLoS One. 2010;5:e15369. |
|
|
|
41.
Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, et al.
The source of human mesenchymal stromal cells influences their TLR profile as
well as their functional properties. Cell Immunol. 2011;270:207-16. |
|
|
|
42.
Raicevic G, Rouas R, Najar M, Stordeur P, Boufker HI, Bron D, et al.
Inflammation modifies the pattern and the function of Toll-like receptors
expressed by human mesenchymal stromal cells. Hum Immunol. 2010;71:235-44. |
|
|
|
43.
Li C, Li B, Dong Z, Gao L, He X, Liao L, et al. Lipopolysaccharide
differentially affects the osteogenic differentiation of periodontal ligament
stem cells and bone marrow mesenchymal stem cells through Toll-like receptor
4 mediated nuclear factor κB pathway. Stem Cell Res Ther. 2014;5:67. |
|
|
|
44.
Mei YB, Zhou WQ, Zhang XY, Wei XJ, Feng ZC. Lipopolysaccharides shapes the
human Wharton's jelly-derived mesenchymal stem cells in vitro. Cell Physiol
Biochem. 2013;32:390-401. |
|
|
|
45.
Tomic S, Djokic J, Vasilijic S, Vucevic D, Todorovic V, Supic G, et al.
Immunomodulatory properties of mesenchymal stem cells derived from dental
pulp and dental follicle are susceptible to activation by toll-like receptor
agonists. Stem Cells Dev. 2011;20:695-708. |
|
|
|
46.
Chatzivasileiou K, Lux CA, Steinhoff G, Lang H. Dental follicle progenitor
cells responses to Porphyromonas gingivalis LPS. J Cell Mol Med.
2013;17:766-73. |
|
|
|
47.
Yamagishi VT, Torneck CD, Friedman S, Huang GT, Glogauer M. Blockade of TLR2
inhibits Porphyromonas gingivalis suppression of mineralized matrix formation
by human dental pulp stem cells. J Endod. 2011;37:812-8. |
|
|
|
48.
Romieu-Mourez R, Franois M, Boivin MN, Bouchentouf M, Spaner DE, Galipeau J.
Cytokine modulation of TLR expression and activation in mesenchymal stromal
cells leads to a proinflammatory phenotype. J Immunol. 2009;1822:7963-73. |
|
|
|
49.
Shi L, Wang JS, Liu XM, Hu XY, Fang Q. Upregulated functional expression of
Toll like receptor 4 in mesenchymal stem cells induced by lipopolysaccharide.
Chin Med J (Engl). 2007;120:1685-8. |
|
|
|
50.
Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, et al. Toll-like
receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature.
1998;395:284-8. |
|
|
|
51.
Good DW, George T, Watts BA. Toll-like receptor 2 is required for LPS-induced
Toll-like receptor 4 signaling and inhibition of ion transport in renal thick
ascending limb. J Biol Chem. 2012;287:20208-20. |
|
|
|
52.
Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin
Immunol. 2005;17:338-44. |
|
|
|
53.
Scannapieco FA, Kornman KS, Coykendall AL. Observation of fimbriae and
flagella in dispersed subgingival dental plaque and fresh bacterial isolates
from periodontal disease. J Periodontal Res. 1983;18:620-33. |
|
|
|
54.
Sela MN. Role of Treponema denticola in periodontal diseases. Crit Rev Oral
Biol Med. 2001;12:399-413. |
|
|
|
55.
Siqueira JF, R™as IN. Bacterial pathogenesis and mediators in apical
periodontitis. Braz Dent J. 2007;18:267-80. |
|
|
|
56.
Ihara H, Miura T, Kato T, Ishihara K, Nakagawa T, Yamada S, et al. Detection
of Campylobacter rectus in periodontitis sites by monoclonal antibodies. J
Periodontal Res. 2003;38:64-72. |
|
|
|
57.
Spratt DA, Weightman AJ, Wade WG. Diversity of oral asaccharolytic
Eubacterium species in periodontitis--identification of novel phylotypes
representing uncultivated taxa. Oral Microbiol Immunol. 1999;14:56-9. |
|
|
|
58.
Xagorari A, Chlichlia K. Toll-like receptors and viruses: induction of innate
antiviral immune responses. Open Microbiol J. 2008;2:49-59. |
|
|
|
59.
Kumagai Y, Kumar H, Koyama S, Kawai T, Takeuchi O, Akira S. Cutting Edge:
TLR-Dependent viral recognition along with type I IFN positive feedback
signaling masks the requirement of viral replication for IFN-{alpha}
production in plasmacytoid dendritic cells. J Immunol. 2009;182:3960-4. |